-
Consano Bio Receives FDA Investigational New Drug Clearance to Expand the C-1101 Chronic Sciatica Clinical Development Program into the United States
- July 20, 2026
- Posted by: Jessica Turner
- Category: Competitive research
No Comments
C-1101 is a potential first-in-class, disease-modifying, non-opioid therapy designed to address the underlying biology of chronic sciaticaBURLINGTON, Mass., July 20, 2026 /PRNewswire/ — Consano Bio, Inc., a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful…
-
Generator Market worth $35.38 billion by 2031 | MarketsandMarkets™
- July 20, 2026
- Posted by:
- Category: News
DELRAY BEACH, Fla., July 20, 2026 /PRNewswire/ — According to MarketsandMarkets™, the global Generator Market size is projected to grow from USD 26.79 billion in 2026 to USD 35.38 billion by 2031 at a compound annual growth rate…
-
Riyadh Air Commits to Purchase 28 Boeing 787 Dreamliners, Adds 787-10 to Future Fleet
- July 20, 2026
- Posted by:
- Category: News
Saudi carrier will exercise options for 28 787 Dreamliner jets from 2023 order and convert 20 options to largest 787 Dreamliner variant Riyadh Air has taken delivery of six 787-9 jets and currently serves six cities Agreement reaffirms Riyadh Air’s plan to operate to over 100 global destinations by 2030, powered by a growing next-generation fleet FARNBOROUGH, United Kingdom, July 20, 2026 /PRNewswire/ — Riyadh Air, the new…